GUILLAIN-BARRE SYNDROME (Syllabus: GS Paper 3 – Sci & Tech)

News-CRUX-10     23rd October 2023        
Samadhaan

Context: In a recent study from Israel, a connection was found between Covid-19 infection and a higher likelihood of being diagnosed with Guillain-Barre syndrome (GBS) within six weeks.

Guillain-Barre Syndrome (GBS)

  • About: This is a rare autoimmune disorder where the body's immune system mistakenly attacks the peripheral nerves.
  • It is more common in adults and males but can affect people of all ages.
  • Symptoms: Initial signs of this syndrome often manifest as sensations of weakness or tingling, typically originating in the legs and potentially extending to affect the arms and facial areas. 

o In certain individuals, these sensations may progress to paralysis in the legs, arms, or facial muscles.

  • Causes: It is frequently preceded by an infection.

o This infection can be either bacterial or viral in nature.

o The most commonly associated infections encompass Campylobacter jejuni, Epstein-Barr virus (EBV), cytomegalovirus (CMV), and the bacteria responsible for pneumonia and urinary tract infections.

  • Treatment: There is currently no cure available for this condition, with the primary treatment being the administration of intravenous immunoglobulin (IVIG).  IVIG is derived from donated blood containing beneficial antibodies.
output themes